Notably, 79% of all epilepsy GWAS participants were recruited from the U.K. The studies spanned genetic/idiopathic generalized epilepsy (childhood absence epilepsy, juvenile myoclonic epilepsy ...

Caplin Steriles Limited has been granted final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application Levetiracetam in Sodium Chloride Injection.

(Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced preliminary unaudited revenue for the quarter and year ended December 31, ...

Caplin Point Laboratories has announced that its subsidiary, Caplin Steriles, has received final nod from United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application ...

Consensus $79.24M. The company said, “Preliminary unaudited revenue for the full year ended December 31, 2024 is expected to be between $79.4 ...